Cell & Gene Therapy

Ensure success for your program.

• Limited technical talent

  Our integrated teams guide your earliest decisions with cross-functional expertise that aligns science, quality, and long-term objectives.

• Unclear development plan

  We design and execute forward-looking, risk-managed programs that reduce downstream issues—and speed your asset through development and approval.

• Complex, time-sensitive submission demands

  Our experienced scientists craft clear, compliant regulatory documents that meet global standards and support every step of the submission process. From authoring and editing to formatting, QC, and coordination, we help clients meet tight timelines for INDs, NDAs, MAAs, and agency briefings—without compromising quality.

• Regulatory uncertainty and evolving expectations

  We help you interpret and apply global regulatory requirements through a fit-for-purpose, risk-based approach grounded in scientific and operational insight. Whether you’re pursuing an IND, NDA, BLA, or global filings, our experts guide you through every step with clarity and precision.

• Pressure to scale quickly

  We accelerate execution across engineering, validation, and operations—helping you avoid multimillion dollar delays and hit your launch window.

   

• Inconsistent documentation or quality gaps

  Our cross-functional experts identify and remediate documentation gaps, harmonize submission standards, and support audit readiness—ensuring your programs meet evolving regulatory expectations even post-launch.

• Missed milestones

  Our integrated model helps clients avoid regulatory setbacks, quality gaps, and disconnected development plans that could delay key milestones—or jeopardize investor confidence.

Trusted by thousands of innovators.

Independent expertise.

Proven playbooks.

Embedded partnership.

End-to-end support.